AMR is moving through animals, farms, and households in the same direction
An editorial in Frontiers in Veterinary Science gathers a series of antimicrobial resistance signals that cut across poultry, captive wildlife, companion animals, and smallholder dairy systems. The common thread is not a single pathogen, but a pattern of selection pressure and mobility: resistance can persist where antibiotics are used, and it can also appear where use is not obvious, documented, or expected.
The article sits squarely in the One Health frame for a reason. Resistant organisms do not respect species boundaries, and neither do the mobile genetic elements that carry them. Once resistance genes enter a population, their spread depends on contact networks, husbandry practices, ecological interfaces, and the routine decisions made in clinics, barns, and households.
One sentence from the evidence stands out with unusual force: colistin resistance turned up in a healthy dog with no reported exposure to colistin.
A healthy dog carried colistin resistance without documented drug pressure
The editorial discusses a colistin-resistant E. coli strain recovered from a healthy dog in Korea. The isolate carried mcr-1 on a conjugative element, a genetic arrangement that matters because conjugation gives resistance the ability to move between bacteria rather than remain trapped in one clonal lineage. In practical terms, this is the sort of molecular architecture that can convert an isolated finding into a broader epidemiologic problem.
Colistin has long occupied a final-line role in antimicrobial therapy. When a transferable resistance determinant appears in a companion animal without a reported history of exposure to that antibiotic, the signal is not merely veterinary. It suggests that resistance determinants can circulate through ecological routes that are difficult to reconstruct after the fact, including food, environment, direct contact, and contaminated shared spaces.
The dog’s lack of documented colistin exposure also sharpens a familiar problem in AMR surveillance: the absence of a recorded exposure does not prove the absence of selection pressure. It may reflect incomplete histories, prior contact with resistant bacteria, or transmission from another reservoir. Either way, the isolate broadens concern beyond treatment decisions made in that single animal.
Poultry, captive wildlife, and the limits of genomic similarity alone
The editorial also cites an epidemiological link between poultry and captive wildlife, while stressing that transmission cannot be established from genomic similarity alone. That caution is essential. Related genomes can point to a shared reservoir or a recent exchange, but they do not, by themselves, reconstruct the direction, timing, or pathway of spread.
In One Health surveillance, this distinction is not academic. Birds in production systems, animals in captive settings, and organisms in surrounding environments can all share overlapping microbial communities. Genomic closeness may reflect direct transmission, indirect environmental contamination, or parallel exposure to similar antimicrobial pressures. Without epidemiologic context, a matching sequence can mislead as easily as it can inform.
The editorial’s treatment of this example reflects a broader truth about AMR investigations: molecular data are powerful, but they require clinical and ecological scaffolding. Sequence data can identify relatedness; they cannot alone explain how a resistance trait moved from one host population to another.
Knowledge is not the same as stewardship in smallholder dairy systems
The article turns from molecular surveillance to behavior, using data from smallholder dairy farmers in Zambia to show how stewardship failures often persist even when attitudes appear favorable. Using the study’s adopted scoring thresholds, approximately 71% of farmers fell below the knowledge threshold and 60% fell below the practice threshold, while 64% held positive attitudes toward prudent antimicrobial use. The gap between attitude and action is the central problem here.
Education alone does not automatically produce stewardship. Tertiary education, cooperative membership, and radio-extension exposure were associated with better knowledge, yet longer farming experience was associated with lower odds of meeting the practice threshold. Experience can harden routine. Habits become efficient, then invisible, and finally difficult to interrupt even when farmers accept the general principle of judicious use.
For AMR control, this is a bedside lesson translated into the field. Information is necessary, but it is not sufficient when behavior is shaped by habit, access, peer norms, economic pressure, and the logistics of livestock care. Interventions that stop at messaging risk missing the deeper mechanisms that determine how drugs are actually used.
Stewardship fails where habits, access, and ecology collide
The editorial’s value lies in the way it places these findings in one frame rather than treating them as unrelated vignettes. Companion animals can harbor transferable resistance genes. Wildlife interfaces can blur ecological boundaries. Dairy farmers can endorse prudent use while still practicing in ways that preserve resistance pressure. Each setting creates its own pathway, but the outcome is the same: selection and spread of antimicrobial resistance across connected systems.
The biology is straightforward enough. Antibiotic exposure favors resistant organisms, and mobile resistance elements accelerate dissemination once they appear. The social biology is more complicated. People and animals move through shared spaces, and antimicrobial decisions are influenced by market demands, local norms, veterinary access, and the realities of daily work. Resistance thrives where those layers overlap.
This is why the article pushes beyond a simple warning about misuse. It argues, through the examples it cites, that AMR control requires surveillance across species, not just within clinics. It also requires stewardship strategies that match the setting. A dairy campaign built only on classroom-style education will not reach the same obstacles as a companion-animal case with no documented exposure or a wildlife interface where transmission routes remain ambiguous.
Surveillance needs to follow the gene, not just the diagnosis
The clearest implication is methodological. AMR surveillance has to track the resistance determinant itself, the host species, and the surrounding ecology at the same time. Genomic similarity may point investigators in the right direction, but transmission claims still need epidemiologic support. Behavioral surveys can reveal knowledge gaps, yet they also need to be read alongside the structural conditions that shape real-world antimicrobial use.
The editorial does not present a single intervention or a definitive solution, and that restraint is appropriate. The article instead assembles evidence showing how easily resistance can pass between compartments that are usually studied separately. Companion animals, livestock systems, poultry, wildlife, and farmers are all part of the same risk network, even when their clinical contexts look distinct on the surface.
The remaining challenge is not whether AMR exists across these systems. It does. The harder question is how surveillance and stewardship programs can be designed tightly enough to catch resistance before it becomes routine, entrenched, and difficult to reverse.